Drug Type Autologous CAR-T |
Synonyms HY 026, HY026 |
Target |
Mechanism EGFRvIII antagonists(Epidermal growth factor receptor variant III antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Juventas Cell Therapy Ltd.Startup |
Active Organization Juventas Cell Therapy Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | CN | Juventas Cell Therapy Ltd.Startup | 08 Nov 2023 |